Merck KGaA
Merck KGaA Extends Collaboration with Quris-AI for Groundbreaking Advancements in Drug Safety
2023-10-02
Proxygen Eligible For €495 Million in Molecular Glue Degrader Collaboration with Merck KGaA
2022-06-06
FDA Approval of Tepotinib Sets Stage for Merck Versus Novartis Showdown in Metastatic NSCLC Space
2021-02-05
LATEST
Study Highlights Improved Outcomes in Mandibular Reconstruction Using Patient-Specific Implants
2026-01-25
Study Explores Role of Peer Recovery Coaches in Substance Use Recovery Programs Across the United States
2026-01-25
Advancements in Genomic Classification of Corynebacterium diphtheriae Strains Address Microbial Resistance Challenges
2026-01-25



